DE69210601D1 - Verfahren zur konditionierung wasserlöslicher substanzen - Google Patents

Verfahren zur konditionierung wasserlöslicher substanzen

Info

Publication number
DE69210601D1
DE69210601D1 DE69210601T DE69210601T DE69210601D1 DE 69210601 D1 DE69210601 D1 DE 69210601D1 DE 69210601 T DE69210601 T DE 69210601T DE 69210601 T DE69210601 T DE 69210601T DE 69210601 D1 DE69210601 D1 DE 69210601D1
Authority
DE
Germany
Prior art keywords
soluble substances
conditioning water
vacuum
water
micronised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69210601T
Other languages
English (en)
Other versions
DE69210601T2 (de
Inventor
Jan Trofast
Eva Trofast
Katarina Bystroem
Edib Jakupovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20382434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69210601(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra AB filed Critical Astra AB
Publication of DE69210601D1 publication Critical patent/DE69210601D1/de
Application granted granted Critical
Publication of DE69210601T2 publication Critical patent/DE69210601T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69210601T 1991-04-11 1992-03-24 Verfahren zur konditionierung wasserlöslicher substanzen Expired - Lifetime DE69210601T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9101090A SE9101090D0 (sv) 1991-04-11 1991-04-11 Process for conditioning of water-soluble substances
PCT/SE1992/000186 WO1992018110A1 (en) 1991-04-11 1992-03-24 Process for conditioning of water-soluble substances

Publications (2)

Publication Number Publication Date
DE69210601D1 true DE69210601D1 (de) 1996-06-13
DE69210601T2 DE69210601T2 (de) 1996-10-02

Family

ID=20382434

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69210601T Expired - Lifetime DE69210601T2 (de) 1991-04-11 1992-03-24 Verfahren zur konditionierung wasserlöslicher substanzen
DE69232207T Expired - Lifetime DE69232207T2 (de) 1991-04-11 1992-03-24 Konditionierte wasserlösliche Substanzen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69232207T Expired - Lifetime DE69232207T2 (de) 1991-04-11 1992-03-24 Konditionierte wasserlösliche Substanzen

Country Status (28)

Country Link
US (1) US5562923A (de)
EP (3) EP0680752B1 (de)
JP (2) JP3400999B2 (de)
KR (1) KR100216384B1 (de)
AT (2) ATE208613T1 (de)
AU (1) AU662519B2 (de)
BG (1) BG61474B1 (de)
CA (1) CA2106975C (de)
CZ (1) CZ286936B6 (de)
DE (2) DE69210601T2 (de)
DK (2) DK0580648T3 (de)
EE (1) EE02970B1 (de)
ES (2) ES2086733T3 (de)
FI (1) FI105388B (de)
GR (1) GR3020602T3 (de)
HK (1) HK52497A (de)
HU (1) HU211116B (de)
IE (1) IE921144A1 (de)
IS (1) IS3834A (de)
NO (1) NO311867B1 (de)
PL (1) PL168232B1 (de)
PT (1) PT680752E (de)
RO (1) RO115779B1 (de)
RU (1) RU2112507C1 (de)
SE (1) SE9101090D0 (de)
SG (1) SG43180A1 (de)
SK (1) SK280310B6 (de)
WO (1) WO1992018110A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
EP0812195B1 (de) * 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Arzneizubereitungen für piperidinalkanolderivate
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
GB9526392D0 (en) * 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
SE9700135D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US6503537B2 (en) 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
US6495167B2 (en) 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
HU226671B1 (en) * 1997-03-20 2009-06-29 Schering Corp Preparation of powder agglomerates
KR100514264B1 (ko) * 1997-08-26 2005-09-15 아벤티스 파마슈티칼스 인크. 피페리디노알칸올-충혈완화제 조합용 제약 조성물
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
ATE239447T1 (de) * 1997-09-29 2003-05-15 Inhale Therapeutic Syst In verneblern verwendbare, stabilisierte zubereitungen
FI105074B (fi) * 1997-12-31 2000-06-15 Leiras Oy Farmaseuttisen formulaation valmistusmenetelmä
US6287693B1 (en) 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
SE9804000D0 (sv) 1998-11-23 1998-11-23 Astra Ab New composition of matter
GB9826286D0 (en) * 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
GB9826284D0 (en) 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7309707B2 (en) 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US20040028746A1 (en) * 2002-08-06 2004-02-12 Sonke Svenson Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
GB0228826D0 (en) * 2002-12-11 2003-01-15 Okpala Joseph Hair technology in creating particles with improved delivery capabilities
EP1511470A2 (de) * 2003-03-26 2005-03-09 Teva Pharmaceutical Industries Ltd. Verfahren zur herstellung eines pharmazeutischen wirkstoffs mit hochspezifischer oberfläche
EP1820494B1 (de) 2003-06-13 2010-01-13 Skendi Finance, Ltd. Mikrosphären von Estradiol und Cholesterol
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
BRPI0415579A (pt) * 2003-10-17 2007-01-02 Du Pont estrutura em multicamadas, embalagem e processo
US7544805B2 (en) 2004-02-03 2009-06-09 Chemagis Ltd. Stable amorphous forms of montelukast sodium
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
DE102004048390A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pulverinhalativa auf Basis modifizierter Laktosemischungen als Hilfsstoff
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
JP2011506399A (ja) * 2007-12-13 2011-03-03 ノバルティス アーゲー 有機化合物
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
US20110224229A1 (en) 2010-03-10 2011-09-15 Astrazeneca Ab Novel Crystalline Form
CA2839398A1 (en) 2011-06-29 2013-01-03 Bayer Intellectual Property Gmbh Crystalline form of indazolyl amide derivatives for the treatment glucocorticoid receptor mediated disorders
JP6454323B2 (ja) * 2013-03-15 2019-01-16 パール セラピューティクス，インコーポレイテッド 粒子状結晶性材料のコンディショニングのための方法及びシステム
WO2021219230A1 (en) 2020-04-30 2021-11-04 Paolo Fiorina Antiviral treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978192A (en) * 1971-09-23 1976-08-31 Sussman Martin V Method of drawing fibers using a microterraced drawing surface
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
US4476130A (en) * 1982-09-09 1984-10-09 Riker Laboratories, Inc. 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity
JPH08186B2 (ja) * 1985-06-21 1996-01-10 ゲルゲリイ、ゲルハルト プロセス材料から反応生成物を製造する方法及びその装置
IT1204826B (it) * 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
CA2030581C (en) * 1989-11-24 2000-06-27 Gunther Atzl Pancreatin preparations
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles

Also Published As

Publication number Publication date
AU1534792A (en) 1992-11-17
ATE208613T1 (de) 2001-11-15
NO311867B1 (no) 2002-02-11
NO933575L (no) 1993-10-06
SK108893A3 (en) 1994-03-09
IE921144A1 (en) 1992-10-21
DE69232207T2 (de) 2002-08-01
FI105388B (fi) 2000-08-15
DE69232207D1 (de) 2001-12-20
IS3834A (is) 1992-10-12
JP2003155228A (ja) 2003-05-27
SK280310B6 (sk) 1999-11-08
ATE137671T1 (de) 1996-05-15
CZ211693A3 (en) 1994-04-13
GR3020602T3 (en) 1996-10-31
EP0680752B1 (de) 2001-11-14
AU662519B2 (en) 1995-09-07
WO1992018110A1 (en) 1992-10-29
EP0508969A1 (de) 1992-10-14
FI934429A (fi) 1993-10-08
BG98147A (bg) 1994-12-02
EP0580648A1 (de) 1994-02-02
HK52497A (en) 1997-05-02
NO933575D0 (no) 1993-10-06
RU2112507C1 (ru) 1998-06-10
ES2168322T3 (es) 2002-06-16
HUT65095A (en) 1994-04-28
EP0680752A3 (de) 1995-11-22
FI934429A0 (fi) 1993-10-08
EP0680752A2 (de) 1995-11-08
CA2106975C (en) 2002-03-19
US5562923A (en) 1996-10-08
SE9101090D0 (sv) 1991-04-11
KR100216384B1 (ko) 1999-08-16
HU9302870D0 (en) 1993-12-28
CZ286936B6 (cs) 2000-08-16
DK0580648T3 (da) 1996-09-16
DK0680752T3 (da) 2002-02-25
SG43180A1 (en) 1997-10-17
JP3400999B2 (ja) 2003-04-28
ES2086733T3 (es) 1996-07-01
JPH06506454A (ja) 1994-07-21
BG61474B1 (en) 1997-09-30
EE02970B1 (et) 1997-04-15
RO115779B1 (ro) 2000-06-30
HU211116B (en) 1995-10-30
EP0580648B1 (de) 1996-05-08
PT680752E (pt) 2002-05-31
DE69210601T2 (de) 1996-10-02
PL168232B1 (pl) 1996-01-31
CA2106975A1 (en) 1992-10-12

Similar Documents

Publication Publication Date Title
DE69210601D1 (de) Verfahren zur konditionierung wasserlöslicher substanzen
RU93058260A (ru) Способ получения водорастворимых микронизированных веществ
CA2211600A1 (en) Apparatus for and method of testing leakage of hollow member
MX166765B (es) Metodo para esterilizar superficies contaminadas microbiologicamente a temperaturas y humedades ambientales
ATE97411T1 (de) Verfahren zur herstellung von taxol.
ES2144868T3 (es) Metodo de tratamiento de superficie por via seca y dispositivo para la aplicacion de un metodo asi.
DE3164422D1 (en) Immunosuppressive compound, process for isolating it and its therapeutical use
NO980861L (no) Granulat med risleevne og basert på organiske syrer, fremgangsmåte for fremstilling, samt anvendelse
DE69205050D1 (de) Verfahren zur Sorption von Restgasen, insbesondere von Stickstoff mittels eines nichtverdampfbaren Bariumgetters.
DE59303465D1 (de) Verfahren zur Reaktivierung eines bei der Herstellung von 1,1,1,2,3,3,3-Heptafluorpropan (R 227) eingesetzten Aktivkohle-Katalysators
ATE124881T1 (de) Verfahren zum trocknen von wasserbenetzten polycarbonatmembranen.
SE8406387D0 (sv) Sperrhjulsanordning
ATE157282T1 (de) Verfahren zur herstellung einer aktiven zusammensetzung und damit hergestellte zusammensetzung
JPS5259212A (en) Vehicle use air cleaner
JPS57156235A (en) Surface treatment of molding rubber material
RU96109577A (ru) Способ проведения оксигенобаротерапии в барокамерах с автономной системой дыхания
JPS644608A (en) Heat-treated fluorinated polymeric compound
JPS5348989A (en) Artificial kidney
JPS5220410A (en) Noise preventiue method of compressor
JPS6440922A (en) Dew condensation preventing method for optical unit
EP1059166B8 (de) Verfahren und Vorrichtung zum Trocknen von Druckerzeugnissen
JPS51131552A (en) A coating method

Legal Events

Date Code Title Description
8364 No opposition during term of opposition